Clinical Trial

Trial Protocol ID USOR 20285_IST-337

Trial Description

A phase II trial of Daratumumab, Lenalidomide and Dexamethasone (DRd) in combination with Selinexor for patients with newly diagnosed multiple myeloma

View on ClinicalTrials.gov

Contact us regarding Clinical Trials at MOHRSCH@usoncology.com or call us at 877-664-7724

Investigator

  • Mohit Narang, M.D.

Disease Types

Sponsor

  • Karyopharm Therapeutics

ClinicalTrials.gov NCT ID

  • NCT04782687